IL6 and graft versus host disease: The effect of bortezomib on GVHD depends on the timing of its administration, as delayed administration causes exacerbation of GVHD in the gut, which is correlated with increased levels of type 1 interferon, TNF, interleukin-1beta (IL-1β) and IL-6 [187].